106
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Adherence to Disease-Modifying Drugs in Patients with Multiple Sclerosis: A Consensus Statement from the Middle East MS Advisory Group

, , , , , , , , , & show all
Pages 273-279 | Received 03 Aug 2009, Published online: 08 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Abdulrahman M. Al Tahan, Isa Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Abdulkader Daif, Dirk Deleu, Khaled Esmat, Dominic Giampaolo, Mark S. Freedman, Michael Gwilt, Hassan Hosny, Jihad S. Inshasi, Mohammed Aljumah, Ahmad Khalifa, Hossein Pakdaman, Miklós Szólics, Bassem I. Yamout, Mohammed A. Sahraian & Magd F. Zakaria. (2014) Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. International Journal of Neuroscience 124:9, pages 635-641.
Read now
Janice L. Jones, Donna J. Scheidt, Ranbir S. Kaushal & Cathryn A. Carroll. (2013) Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis. Journal of Medical Economics 16:2, pages 213-220.
Read now
Izabella Lejbkowicz, Opher Caspi & Ariel Miller. (2012) Participatory medicine and patient empowerment towards personalized healthcare in multiple sclerosis. Expert Review of Neurotherapeutics 12:3, pages 343-352.
Read now
Dirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, Abdel Rahman Al Tahan, Saeed Bohlega, Maurice Dahdaleh, Jihad Inshasi, Ahmad Khalifa, Miklos Szólics & Bassem I. Yamout. (2011) Will New Injection Devices for Interferon Beta-1a s.c. Affect Treatment Adherence in Patients With Multiple Sclerosis? An Expert Opinion in the Middle East. International Journal of Neuroscience 121:4, pages 171-175.
Read now

Articles from other publishers (4)

Mai F. Alsaqa’aby, Varun Vaidya, Noura Khreis, Thamer Al Khairallah & Ahmed H. Al-jedai. (2017) Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia. Annals of Saudi Medicine 37:6, pages 433-443.
Crossref
Todd M. Ruppar, Fabienne Dobbels, Pawel Lewek, Michal Matyjaszczyk, Kaat Siebens & Sabina M. De Geest. (2015) Systematic Review of Clinical Practice Guidelines for the Improvement of Medication Adherence. International Journal of Behavioral Medicine 22:6, pages 699-708.
Crossref
Mohammed Aljumah, Raed Alroughani, I. Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Dirk Deleu, Khaled Esmat, Ahmad Khalifa, Mohammad A. Sahraian, Miklós Szólics, Abdulrahman AlTahan, Bassem I. Yamout, Peter Rieckmann & Abdulkader Daif. (2013) Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries. Multiple Sclerosis International 2013, pages 1-6.
Crossref
Raed Alroughani & Anil Thussu. (2012) Adherence to First-Line Disease-Modifying Therapy for Multiple Sclerosis in Kuwait. International Journal of MS Care 14:1, pages 17-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.